Business Context and Reporting Period
This Form 8-K Current Report was filed by Wrap Technologies, Inc. on April 21, 2023. The report details significant changes to the Company's Board of Directors, including new appointments and a director's decision not to seek re-election.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and personnel changes.
Material Changes
- Board Appointments: On April 21, 2023, the Company appointed three new directors:
- Kevin Mullins: Appointed as a director. He currently serves as CEO (since April 13, 2023) and President (since April 18, 2022). No equity compensation was disclosed for this specific appointment.
- Bruce T. Bernstein: Appointed as a director. He was granted options to purchase 30,000 shares at an exercise price of $1.34 per share. The options vest 50% on April 21, 2024, and the remaining 50% in quarterly installments over the following year.
- Marc Savas: Appointed as a director. He was granted options to purchase 30,000 shares at an exercise price of $1.34 per share, with the same vesting schedule as Mr. Bernstein.
- Director Departure: Kimberly Sentovich informed the Company she will not stand for re-election at the 2023 Annual Meeting. This decision was not due to any disagreement with the Company.
- All of Ms. Sentovich's unvested restricted share units will be cancelled.
- All of her outstanding options will expire 90 days after the 2023 Annual Meeting.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on future business performance. It does not disclose new material risks or contingencies beyond the standard disclosure that there are no related party transactions requiring disclosure under Item 404(a) of Regulation S-K for the new appointees.
Investor Verification Checklist
- Verify the impact of the new board composition on the Company's strategic direction, particularly given the backgrounds of Messrs. Bernstein (securities/arbitrage) and Savas (revenue acceleration/consulting).
- Confirm the dilution impact of the 60,000 new options granted to Messrs. Bernstein and Savas at the $1.34 exercise price.
- Review the Company's upcoming 2023 Annual Meeting proxy statement to confirm the final slate of director nominees following Ms. Sentovich's departure.
- Check subsequent filings for any financial updates, as this 8-K contains no financial data.